Pre-treatment Endorectal Coil MRI Findings Predict Biochemical Tumor Control in Prostate Cancer Patients Treated with Combination Brachytherapy and External Beam Radiotherapy

被引：0
|
作者：
Riaz, N. [1 ]
Afaq, A. [1 ]
Pei, X. [1 ]
Akin, O. [1 ]
Zelefsky, M. J. [1 ]
机构：
[1] Mem Sloan Kettering, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S387 / S387
页数：1
相关论文
共 50 条
  • [31] Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
    C C Parker
    A R Norman
    R A Huddart
    A Horwich
    D P Dearnaley
    British Journal of Cancer, 2002, 86 : 686 - 691
  • [32] Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
    Parker, CC
    Norman, AR
    Huddart, RA
    Horwich, A
    Dearnaley, DP
    BRITISH JOURNAL OF CANCER, 2002, 86 (05) : 686 - 691
  • [33] Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA
    Merrick, Gregory S.
    Galbreath, Robert W.
    Butler, Wayne M.
    Fiano, Ryan
    Adamovich, Edward
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (04) : 297 - 303
  • [34] Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapy
    Taira, Al V.
    Merrick, Gregory S.
    Galbreath, Robert W.
    Butler, Wayne M.
    Lief, Jonathan H.
    Adamovich, Edward
    Wallner, Kent E.
    BRACHYTHERAPY, 2013, 12 (05) : 408 - 414
  • [35] Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone
    Andruska, Neal
    Fischer-Valuck, Benjamin W.
    Carmona, Ruben
    Agabalogun, Temitope
    Brenneman, Randall J.
    Gay, Hiram A.
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (04): : 343 - +
  • [36] Quality of life in intermediate or high risk prostate cancer patients treated by external beam radiotherapy and brachytherapy with or without androgen deprivation
    Lacorte-Pi, T. M.
    Guix-Melcior, B.
    Guedea-Edo, F.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S296 - S297
  • [37] Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study
    Wang, H.
    Mendez, L. C.
    Morton, G.
    Loblaw, A.
    Mesci, A.
    Chung, H. T.
    Chan, S.
    Huang, X.
    Downes, M. R.
    Vesprini, D.
    Liu, S. K.
    RADIOTHERAPY AND ONCOLOGY, 2021, 155 : 80 - 85
  • [38] Using Deformable Registration to Evaluate Combined Biological Effective Dose in Patients Receiving Combination External Beam Radiotherapy and Brachytherapy of Prostate Cancer Patients
    不详
    MEDICAL PHYSICS, 2011, 38 (06)
  • [39] Impact of magnetic resonance imaging (MRI) in the local staging, risk group classification, and treatment of patients with prostate cancer with combination of high dose rate (HDR) brachytherapy and external beam radiotherapy (EBRT)
    Gomez-Iturriaga, Alfonso
    Casquero, Francisco
    Carvajal, Claudia
    Urresola, Arantxa
    Canteli, Begona
    Ezquerro, Ana
    Hortelano, Eduardo
    San Miguel, Inigo
    Cacicedo, Jon
    Llarena, Roberto
    Martinez-Indart, Lorea
    Maria Espinosa, Jose
    Minguez, Pablo
    Bilbao, Pedro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [40] Lack of benefit for neoadjuvant androgen deprivation in patients with locally advanced prostate cancer treated with a combination of external beam radiotherapy and conformal high dose rate brachytherapy as boost
    Pataki, I
    Martinez, AA
    Edmundson, GK
    Sebastian, E
    Vicini, FA
    Chen, PY
    RADIOLOGY, 2000, 217 : 213 - 214
12345